SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-19-024249
Filing Date
2019-11-21
Accepted
2019-11-21 06:03:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b4112019a_delmarpharma.htm 424B4 153507
2 GRAPHIC image_001.jpg GRAPHIC 26883
3 GRAPHIC image_002.jpg GRAPHIC 35226
  Complete submission text file 0001213900-19-024249.txt   240393
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 424B4 | Act: 33 | File No.: 333-232332 | Film No.: 191235607
SIC: 2834 Pharmaceutical Preparations